Order Article Reprints

Khaemba C, Barry A, Omondi WP, Bota K, Matendechero S, Wandera C, Siyoi F, Kirui E, Oluka M, Nambwa P, et al. Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study. Pharmaceuticals. 2021; 14(3):264. https://doi.org/10.3390/ph14030264

Khaemba, Christabel, Abbie Barry, Wyckliff P. Omondi, Kefa Bota, Sultani Matendechero, Cecilia Wandera, Fred Siyoi, Elvis Kirui, Margaret Oluka, Pamela Nambwa, and et al. 2021. "Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study" Pharmaceuticals 14, no. 3: 264. https://doi.org/10.3390/ph14030264

Khaemba, C., Barry, A., Omondi, W. P., Bota, K., Matendechero, S., Wandera, C., Siyoi, F., Kirui, E., Oluka, M., Nambwa, P., Gurumurthy, P., Njenga, S. M., Guantai, A., & Aklillu, E. (2021). Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study. Pharmaceuticals, 14(3), 264. https://doi.org/10.3390/ph14030264